https://www.selleckchem.com/pr....oducts/ch5424802.htm
98, 95% CI 0.88, 1.08; ARBs vs others=1.00, 95% CI 0.90, 1.11) after applying inverse probability of treatment weights. These associations were consistent across racial/ethnic groups. Use of ACEIs or ARBs during hospitalization was associated with a lower risk of all-cause mortality (odds ratios for ACEIs or ARBs vs others=0.50, 95% CI 0.34, 0.72). Our study findings support continuation of ACEI or ARB use for patients with hypertension during the COVID-19 pandemic and after COVID-19 infection. Our study findings support continuation
Like
Comment
Share
